Get startedLog in
    Picture of SAI Life Sciences logo

    SAILIFE — SAI Life Sciences Cashflow Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMid CapHigh Flyer
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for SAI Life Sciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    Period Length:12 M12 M12 M
    Source:PROSPECTUSPROSPECTUSPROSPECTUS
    Standards:
    IAS
    IAS
    IAS
    Status:FinalFinalFinal
    Net Income/Starting Line971641,092
    Depreciation
    Non-Cash Items377727865
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-327308-521
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities1,0492,1942,631
    Capital Expenditures-2,069-1,131-1,817
    Purchase of Fixed Assets
    Other Investing Cash Flow Items1,032113-107
    Sale of Fixed Assets
    Change in Net Investments
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-1,037-1,018-1,924
    Financing Cash Flow Items-501-785-853
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities719-2,006-953
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash752-802-236